Literature DB >> 20073578

Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): pattern changes from inflammation to prostate cancer.

Alessandro Sciarra1, Valeria Panebianco, Mauro Ciccariello, Stefano Salciccia, Danilo Lisi, Marcello Osimani, Andrea Alfarone, Alessandro Gentilucci, Ulderico Parente, Roberto Passariello, Vincenzo Gentile.   

Abstract

PURPOSE: To assess (1)H-magnetic resonance spectroscopic imaging ((1)H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI) features in histologically confirmed prostatic chronic inflammation, prostatic intraepithelial neoplasia (PIN), low grade prostate cancer (LGPCa), and high grade prostate cancer (HGPCa).
MATERIALS AND METHODS: Ninety-six men were selected, who showed at histology a diagnosis of chronic inflammation (Group B), high grade (HG) PIN (Group C), or prostate cancer (LGPCa = Group D and HGPCa = Group E).
RESULTS: ANOVA analysis shows that inflammation (Group B) displays no significantly (p >.05) different choline and citrate levels when compared to HGPIN and LGPCa.
CONCLUSION: our results suggest the potential for these MR imaging techniques in the description of inflammatory and proliferative lesions inside the prostate gland.

Entities:  

Mesh:

Year:  2010        PMID: 20073578     DOI: 10.3109/07357900903287048

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  11 in total

Review 1.  Advancements in MR imaging of the prostate: from diagnosis to interventions.

Authors:  David Bonekamp; Michael A Jacobs; Riham El-Khouli; Dan Stoianovici; Katarzyna J Macura
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

2.  Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

Authors:  Matthew J Roberts; Horst J Schirra; Martin F Lavin; Robert A Gardiner
Journal:  Korean J Urol       Date:  2011-02-19

Review 3.  Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?

Authors:  Samuel A Gold; Graham R Hale; Jonathan B Bloom; Clayton P Smith; Kareem N Rayn; Vladimir Valera; Bradford J Wood; Peter L Choyke; Baris Turkbey; Peter A Pinto
Journal:  World J Urol       Date:  2018-05-21       Impact factor: 4.226

Review 4.  The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer.

Authors:  Yishen Wang; Joao R Galante; Athar Haroon; Simon Wan; Asim Afaq; Heather Payne; Jamshed Bomanji; Sola Adeleke; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2022-07-04       Impact factor: 16.430

Review 5.  Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.

Authors:  Yu Xuan Kitzing; Adilson Prando; Celi Varol; Gregory S Karczmar; Fiona Maclean; Aytekin Oto
Journal:  Radiographics       Date:  2015-11-20       Impact factor: 5.333

6.  Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.

Authors:  Pieter J L De Visschere; Anne Vral; Gianpaolo Perletti; Eva Pattyn; Marleen Praet; Vittorio Magri; Geert M Villeirs
Journal:  Eur Radiol       Date:  2016-08-04       Impact factor: 5.315

Review 7.  Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.

Authors:  Stefano Salciccia; Anna Laura Capriotti; Aldo Laganà; Stefano Fais; Mariantonia Logozzi; Ettore De Berardinis; Gian Maria Busetto; Giovanni Battista Di Pierro; Gian Piero Ricciuti; Francesco Del Giudice; Alessandro Sciarra; Peter R Carroll; Matthew R Cooperberg; Beatrice Sciarra; Martina Maggi
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

8.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

9.  Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer.

Authors:  Michael S Leapman; Zhen J Wang; Spencer C Behr; John Kurhanewicz; Ronald J Zagoria; Peter R Carroll; Antonio C Westphalen
Journal:  Radiol Bras       Date:  2017 Sep-Oct

10.  3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.

Authors:  Hans Christian Rischke; Ursula Nestle; Tobias Fechter; Christian Doll; Natalja Volegova-Neher; Karl Henne; Jutta Scholber; Stefan Knippen; Simon Kirste; Anca L Grosu; Cordula A Jilg
Journal:  Radiat Oncol       Date:  2013-07-22       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.